Robert Y. Clagett
directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026
Highest-materiality recent filing
Primis Financial Q1 operating net income $8.1M, up 126% YoY; declares $0.10 dividend
Q1 operating net income $8.1M ($0.33 diluted EPS), up 126% from $3.6M ($0.14) in Q1 2025.
Primis Financial Q4 net income $30M ($1.20 EPS); NIM 3.28%; TBV $13.34; dividend $0.10
Q4 2025 net income $30M vs net loss $23M in Q4 2024; diluted EPS $1.20 vs ($0.94).
Primis Financial sale-leaseback of 18 branches expects $50M pre-tax gain, 13.2% TBV accretion
Sale of 18 branch properties for ~$58M; pre-tax gain of $50M ($38M after-tax, $1.54 per share).
Primis Financial Q3 net income $7M ($0.28 EPS) vs $1M ($0.05) YoY; dividend $0.10
Net income available to common $7M ($0.28 diluted EPS) vs $1M ($0.05) in Q3 2024; 9-month EPS $1.29 vs $0.29.
Primis Financial restates Q2 net income to $2.4M on loan downgrades; EPS $0.10
Downgraded three performing loans: $6.4M to special mention, $30.7M office to substandard accruing, $40.1M office to substandard nonaccrual with $7.7M specific reserve.
Primis Financial Q2 EPS $0.34 (vs $0.14); NIM 2.89%; dividend $0.10
Diluted EPS $0.34 vs $0.14 in Q2 2024; net income $8.4M vs $3.4M.
Primis Q1 EPS $0.92, includes $0.81 gain from PFH deconsolidation
Net income $22.6M, diluted EPS $0.92; includes $20.0M after-tax gain on PFH deconsolidation ($0.81/share).
Primis restates Q4 2024 net loss to $23.3M; amends for reserve and fraud adjustments
Net loss of $0.94 per diluted share for Q4 2024 vs $0.33 loss a year ago; full-year loss $0.66 vs $0.32.
Primis Financial Q1 net income $2.7M vs. Q4 loss $23.3M; declares $0.10 dividend
EPS of $0.11 vs. loss of $0.94 in Q4 2024; normalized net income $5.1M after $1.9M consumer loan provision.
Primis Financial gets Nasdaq delisting hearing set for May 15, stay granted
Nasdaq Hearings Panel scheduled hearing for May 15, 2025, staying delisting pending final decision.
Received Nasdaq Staff notice on April 3, 2025 for failure to timely file FY2024 10-K.
Primis Financial reports Q4 net loss of $14.7M; moves consumer loans to held-for-sale
Net loss available to common shareholders of $14.7M ($0.59 loss per share) in Q4 2024 vs loss of $8.2M ($0.33) in Q4 2023.
Primis regains Nasdaq compliance, authorizes 740,600 share buyback
Board authorized repurchase of up to 740,600 shares from Dec 19, 2024 to Dec 19, 2025.
Primis Financial receives additional Nasdaq notice for delayed Q2 and Q3 10-Qs
Received Nasdaq notice on Nov 21, 2024 for continued noncompliance with Listing Rule 5250(c)(1).
Primis Financial completes sale of Life Premium Finance division to EverBank for $6 million premium
Primis Bank sold approximately $354 million of Life Premium Finance loans to EverBank on October 31, 2024.
Q3 net income available to common $1.2M ($0.05 diluted) vs loss of $6.0M a year ago; operating EPS $0.08 vs $0.21.
Primis Financial receives Nasdaq stay extension until Dec 3 hearing on delisting
Nasdaq extended temporary stay of delisting pending Panel hearing on December 3, 2024.
Forvis Mazars declined reappointment as auditor for FY 2024; notified Sep 17, 2024.
Filed restated 2022 Form 10-K/A on Oct 4; expects to file 2023 Form 10-K on Oct 11.
Forvis Mazars declines re-appointment as Primis Financial auditor; material weaknesses cited
Forvis will not stand for re-appointment for FY2024; decision dated Sept 17, 2024, ratified by Audit Committee.
Primis Financial restates 2022 financials; cites material weakness in internal controls
2022 audited financial statements and audit report no longer reliable due to errors in accounting for third-party serviced consumer loans.
Primis Financial receives Nasdaq delinquency notice for late filings; granted until Sept 30
Received Nasdaq notice on Aug 21, 2024 for failure to timely file 2023 10-K, Q1 and Q2 2024 10-Qs.
SEC non-objection on Aug 9 to multi-unit accounting for consumer loan program; company to restate 2023 and 2024 interim results.
Primis Financial reports Q2 2024 EPS $0.32, turns profitable; declares $0.10 dividend
Net income available to common $7.8M vs loss $0.3M in Q2 2023; diluted EPS $0.32 vs ($0.01).
Primis Financial receives Nasdaq delinquency notice for late filings due to restatement
Received Nasdaq notice on May 16, 2024 for failure to timely file 2023 10-K and Q1 2024 10-Q.
directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026
the Board appointed Scott R. Gamble to the Company and Bank boards
directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026
Max materiality 0.85 · Median 0.75 · Most common event earnings